Overall rank by patents
#2,636
of 49,997 tracked assignees
USPTO PatentsView assignee record - 147 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Angiodynamics ranks #2,636 of 49,997 tracked US assignees by granted-patent volume, with 147 patents across 16 technology areas.
USPTO PatentsView assignee plate
Corpus R2636 · US Corporation #2,636 · 147 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Aircelle (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
AngioDynamics · this assignee
43 score
AZ Materials… · near
43 score
Bromine Compounds · near
43 score
The AES · near
43 score
UEA Enterprises · near
43 score
3D Lighting… · lowest
7 score
What this shows Angiodynamics's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
AngioDynamics, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 57.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (21 grants) versus a trough of 5 in 2022. By volume, Angiodynamics sits between Ocient Holdings LLC and Hitachi Vantara, Ltd..
From 2019–2021 to 2022–2024, AngioDynamics, Inc. moved from 44 to 23 grants (0.52x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,634. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ocient Holdings LLC
148 patents
The University Of Queensland
148 patents
ZF Automotive Germany GmbH
148 patents
Aircelle
147 patents
Blue Yonder Group, Inc.
147 patents
Cleversafe, Inc.
147 patents
GIESECKE+DEVRIENT Mobile Security GMBH
147 patents
Hitachi Vantara, Ltd.
147 patents
AngioDynamics, Inc.
147 patents
What this shows AngioDynamics holds 147 patents at rank #2,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,636 in granted patent volume.
Other assignees with the most granted patents in AngioDynamics's primary technology class.
Two PlainPatent-derived peer sets for AngioDynamics, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (43 here).
Nearest assignees by average claims per patent (14.3 here).
Angiodynamics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 28% higher than 72% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 12.2% |
| 2016 | 16 | 10.9% |
| 2017 | 15 | 10.2% |
| 2018 | 21 | 14.3% |
| 2019 | 17 | 11.6% |
| 2020 | 19 | 12.9% |
| 2021 | 8 | 5.4% |
| 2022 | 5 | 3.4% |
| 2023 | 8 | 5.4% |
| 2024 | 10 | 6.8% |
| 2025partial year | 10 | 6.8% |
Top 15 of 16 technology areas
Overall rank by patents
#2,636
of 49,997 tracked assignees
43.5 out of 100
What to do with this data
AngioDynamics, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.